StonvexLoading…
StonvexStonvexStonvexCore line items from GNRC's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $1.06B | $4.21B | $3.12B | $2.00B |
Operating Income | $117.29M | $289.19M | $298.51M | $195.43M |
Net Income | $73.25M | $159.55M | $184.02M | $117.86M |
EPS (Diluted) | $1.24 | $2.69 | $3.10 | $1.98 |
Total Assets | $5.59B | $5.57B | $5.60B | $5.39B |
Total Liabilities | $2.92B | $2.93B | $2.95B | $2.81B |
Cash & Equivalents | $265.53M | $341.41M | $300.01M | $223.53M |
Free Cash Flow OCF − CapEx | $89.89M | $268.13M | $138.19M | $41.69M |
Shares Outstanding | 59.23M | 59.28M | 59.31M | 59.39M |